We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+4.67%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.05B
AUM Growth
+$276M
(+4.1%)
Cap. Flow
+$73M
Cap. Flow
% of AUM
1.04%
Top 10 Holdings %
Top 10 Hldgs %
27.96%
Holding
1,430
New
433
Increased
334
Reduced
305
Closed
319
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$182M |
| 2 |
ENDP
Endo International plc
ENDP
|
+$170M |
| 3 |
AET
Aetna Inc
AET
|
+$131M |
| 4 |
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
|
+$108M |
| 5 |
Brookdale Senior Living
BKD
|
+$91.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$435M |
| 2 |
Elevance Health
ELV
|
+$121M |
| 3 |
Cigna
CI
|
+$119M |
| 4 |
WMGI
Wright Medical Group Inc
WMGI
|
+$82.7M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$72.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 49.34% |
| 2 | Financials | 7.86% |
| 3 | Consumer Discretionary | 7.17% |
| 4 | Technology | 6.32% |
| 5 | Industrials | 4.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
Green Dot
GDOT
$743M
| $294K | ﹤0.01% |
+15,392
| New | +$250K |
|
|
MDC
802
DELISTED
M.D.C. Holdings, Inc.
MDC
| $294K | ﹤0.01% |
+13,611
| New | +$278K |
|
803
Gentex
GNTX
$4.97B
| $293K | ﹤0.01% |
+17,853
| New | +$312K |
|
804
Iovance Biotherapeutics
IOVA
$1.82B
| $293K | ﹤0.01% |
+32,000
| New | +$357K |
|
|
RDC
805
DELISTED
Rowan Companies Plc
RDC
| $293K | ﹤0.01% |
+13,880
| New | +$294K |
|
|
WDR
806
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $292K | ﹤0.01% |
+6,180
| New | +$301K |
|
|
RYL
807
DELISTED
RYLAND GROUP INC
RYL
| $292K | ﹤0.01% |
+6,300
| New | +$280K |
|
808
PVH
PVH
$4B
| $291K | ﹤0.01% |
2,529
-2,640
| -51% | -$287K |
|
809
SLR Investment Corp
SLRC
$686M
| $291K | ﹤0.01% |
16,168
-3,325
| -17% | -$64.4K |
|
810
Timken Company
TKR
$9.56B
| $291K | ﹤0.01% |
+7,957
| New | +$317K |
|
811
Terex
TEX
$7.18B
| $290K | ﹤0.01% |
+12,468
| New | +$329K |
|
|
STI
812
DELISTED
SunTrust Banks, Inc.
STI
| $289K | ﹤0.01% |
6,714
+1,014
| +18% | +$43.1K |
|
813
Glacier Bancorp
GBCI
$6.42B
| $287K | ﹤0.01% |
+9,756
| New | +$268K |
|
|
GPT
814
DELISTED
Gramercy Property Trust
GPT
| $285K | ﹤0.01% |
+4,068
| New | +$327K |
|
|
RDUS
815
DELISTED
Radius Health, Inc.
RDUS
| $284K | ﹤0.01% |
+4,200
| New | +$196K |
|
|
IMPV
816
DELISTED
Imperva, Inc.
IMPV
| $284K | ﹤0.01% |
4,190
-48,310
| -92% | -$2.67M |
|
|
CA
817
DELISTED
CA, Inc.
CA
| $284K | ﹤0.01% |
9,711
+1,564
| +19% | +$48.6K |
|
818
Bath & Body Works
BBWI
$4.06B
| $283K | ﹤0.01% |
+4,077
| New | +$293K |
|
819
Entergy
ETR
$50.2B
| $283K | ﹤0.01% |
8,032
-8,034
| -50% | -$302K |
|
|
CELG
820
DELISTED
Celgene Corp
CELG
| $283K | ﹤0.01% |
2,448
-952
| -28% | -$109K |
|
821
Cintas
CTAS
$81.9B
| $282K | ﹤0.01% |
13,336
-19,540
| -59% | -$410K |
|
|
SWI
822
DELISTED
SOLARWINDS INC COM STK (DE)
SWI
| $282K | ﹤0.01% |
6,115
-43,485
| -88% | -$2.14M |
|
823
Churchill Downs
CHDN
$5.88B
| $281K | ﹤0.01% |
+13,506
| New | +$273K |
|
824
Universal Corp
UVV
$1.31B
| $281K | ﹤0.01% |
+4,900
| New | +$248K |
|
|
NLSN
825
DELISTED
Nielsen Holdings plc
NLSN
| $281K | ﹤0.01% |
+6,286
| New | +$285K |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q2 2015 Portfolio in Review
As of Q2 2015, Visium Asset Management held 1,430 positions worth $7.05B, up 4.1% from $6.78B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Visium Asset Management's Q2 2015 filing shows 433 new, 334 increased, 305 reduced and 319 closed positions. Its largest new stake was Sio Gene Therapies Inc. Common Stock: 635,000 shares worth $104M. The largest sale was Allergan plc, an estimated $435M.
By sector, the portfolio is most concentrated in Healthcare at 49% of assets, down from 49% a quarter earlier, followed by Financials and Consumer Discretionary.
- Visium Asset Management's largest Q2 2015 buy was Sio Gene Therapies Inc. Common Stock: 635,000 shares worth $104M.
- Visium Asset Management added most to Bausch Health in Q2 2015, an estimated $182M increase.
- Visium Asset Management's biggest Q2 2015 reduction was Elevance Health, cutting an estimated $121M.
- Visium Asset Management fully exited Allergan plc in Q2 2015, selling an estimated $435M.
- Visium Asset Management's ten largest holdings make up 28% of its $7.05B portfolio in Q2 2015.
- Visium Asset Management opened 433 new positions and closed 319 in Q2 2015.
- Visium Asset Management's portfolio value rose 4.1% quarter-over-quarter to $7.05B.
Based on Visium Asset Management's 13F filing for Q2 2015, filed 14 Aug 2015.